Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × ITCH × Prednisone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 130 Lymphoma 117 Lymphoma, Large B-Cell, Diffuse 79 Precursor Cell Lymphoblastic Leukemia-Lymphoma 55 Multiple Myeloma 50 Lymphoma, Non-Hodgkin 46 Lymphoma, Follicular 45 Leukemia 39 Hodgkin Disease 33 Lymphoma, Mantle-Cell 32 Burkitt Lymphoma 31 Lymphoma, Large-Cell, Immunoblastic 21 Lymphoma, Large-Cell, Anaplastic 20 Lymphoma, B-Cell, Marginal Zone 19 Neoplasm Metastasis 16 Leukemia, Lymphocytic, Chronic, B-Cell 16 Neoplasms, Plasma Cell 15 Neoplasms 13 Lymphoma, T-Cell, Peripheral 10 Dendritic Cell Sarcoma, Interdigitating 10 Recurrence 9 Lymphoma, B-Cell 9 Primary Myelofibrosis 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Immunoblastic Lymphadenopathy 8 Blast Crisis 7 Lymphoma, T-Cell 6 Graft vs Host Disease 6 Waldenstrom Macroglobulinemia 5 Polycythemia Vera 5

Interventions

fexofenadine 1 Prednisone 1 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01683552 2012-09-12

AprepIt

Campus Bio-Medico University

Phase 2 Completed

ITCH

Data powered by HemOnc (CC BY 4.0) Colophon ⚡